Clinical trial
A Randomized Controlled Trial of Pioglitazone on Insulin Resistance, Insulin Secretion and Atherosclerosis in Renal Allograft Recipients Without History of Diabetes
NCT00598013 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial of Pioglitazone on Insulin Resistance, Insulin Secretion and Atherosclerosis in Renal Allograft Recipients Without History of Diabetes
- Lead sponsor
- Yonsei University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2004
- Completion date
- November 30, 2007
- Enrollment
- 83 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis, insulin resistance, kidney transplantation